1. Introduction {#sec1-nutrients-12-00005}
===============

Cardiovascular disease (CVD) is responsible for 31 percent of all deaths worldwide (WHO 2018). The onset of CVD is preceded for decades by subclinical vascular functional and/or structural alterations, leading to transient or permanent subclinical arterial damage (SAD). Major types of SAD include atheromatosis (arterial atheromatic plaque formation), arteriosclerosis (arterial stiffening due to loss of the arterial wall's elastic properties) and arterial remodeling (changes in arterial wall and lumen dimensions to maintain mechanical homeostasis). All the above modifications may occur simultaneously or separately.

In the last decade, a range of reliable, non-invasive vascular biomarkers have been used to detect SAD. Carotid ultrasonography is widely used to detect structural changes in the arterial wall (such as arterial plaques, indices of arterial remodeling, e.g., carotid intima--media thickness (cIMT) and arterial lumen diameters) \[[@B1-nutrients-12-00005],[@B2-nutrients-12-00005],[@B3-nutrients-12-00005]\]. On the other hand, arterial stiffening is classically measured by applanation tonometry to obtain carotid--femoral pulse wave velocity (cfPWV), the gold standard for clinical practice, although other methods have been used \[[@B3-nutrients-12-00005]\]. The study of these vascular biomarkers provides the opportunity to not only optimize CVD risk classification but also to elucidate the pathogenesis and pathophysiology of CVD in the early clinical steps.

Globally, sodium (Na) intake is almost double (mean intake: 3.95 g/day) \[[@B4-nutrients-12-00005]\] the recommended levels by the World Health Organization (less than 2 g/day) \[[@B5-nutrients-12-00005]\]. High Na intake has been strongly correlated with CVD \[[@B6-nutrients-12-00005],[@B7-nutrients-12-00005],[@B8-nutrients-12-00005]\]. Moreover, there is strong evidence from large-scale studies of a blood pressure (BP)-lowering effect (by 3.39 mmHg for systolic BP and 1.54 mmHg for diastolic BP)---and consequently CVD-risk lowering effect---after a reduction in Na intake to less than 2 g/day compared to an intake higher than 2 g/day \[[@B8-nutrients-12-00005]\]. However, very low levels of Na intake (approximately below 1.5 g/day) have also been linked to increasing CVD risk, suggesting a J-shaped trend \[[@B9-nutrients-12-00005],[@B10-nutrients-12-00005],[@B11-nutrients-12-00005],[@B12-nutrients-12-00005],[@B13-nutrients-12-00005],[@B14-nutrients-12-00005]\]. Although the effect of salt on BP is variable due to salt sensitivity subtypes, consideration of this heterogeneity has been neglected in previous meta-analyses \[[@B9-nutrients-12-00005],[@B10-nutrients-12-00005]\]. Several observational and/or interventional studies have tested the association of Na intake with types of SAD, but there are still many contradictory results and questions to be addressed \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005]\]. Most data derive from studies investigating the relationship between Na and arterial stiffness or hypertrophy, suggesting that higher levels of Na intake are positively associated with these types of SAD \[[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B21-nutrients-12-00005]\], although this has not been seen consistently \[[@B16-nutrients-12-00005],[@B17-nutrients-12-00005],[@B18-nutrients-12-00005]\]. Studies regarding dietary Na and atheromatosis are scarce and are limited by major methodological issues \[[@B19-nutrients-12-00005],[@B20-nutrients-12-00005]\].

In an attempt to better understand the potential associations that link dietary Na intake and SAD, the aim of this systematic review is to evaluate---for the first time---data from observational and interventional studies in humans, investigating associations between dietary Na intake and SAD as well as the effect of Na intake on SAD-related changes. All types of SAD were considered, namely (i) atheromatosis (arterial plaques); (ii) arteriosclerosis (arterial stiffening); (iii) arterial remodeling (intima--media thickening and arterial lumen diameters).

2. Materials and Methods {#sec2-nutrients-12-00005}
========================

This study was prepared and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@B21-nutrients-12-00005]\] ([Appendix A](#app1-nutrients-12-00005){ref-type="app"}).

2.1. Search Strategy {#sec2dot1-nutrients-12-00005}
--------------------

A systematic search of potentially relevant studies was performed through July 2019 by two separate reviewers on the PUBMED and SCOPUS databases. Search terms applied were: (("sodium intake" or "na intake" or "na+ intake" or "sodium excretion" or "na excretion" or "na+ excretion" or "dietary sodium" or "dietary na" or "dietary na+" or "urinary sodium" or "urinary na" or "urinary na+")) and ("arterial function" or "vascular function" or "arterial structure" or "vascular structure" or plaque or atheroma or "atheromatic plaque" or "atherosclerotic plaque" or atheromatosis or atherosclerosis or arteriosclerosis or "arterial remodeling" or "carotid plaque" or "femoral plaque" or "arterial stiffness" or "arterial stiffening" or "pulse wave velocity" or pwv or "intimal medial thickness" or "intima media thickness" or IMT or "wall to lumen ratio"). Studies were limited to the English language and human studies. Reference lists of included articles were also examined for additional relevant articles.

2.2. Inclusion and Exclusion Criteria {#sec2dot2-nutrients-12-00005}
-------------------------------------

The following inclusion criteria were applied: relevant epidemiological studies or clinical trials, English language, human studies, males and/or females of any age regardless of diseases (chronic or acute), clearly described outcome defined as: association between Na intake and/or excretion with atheromatosis (presence of plaques), arteriosclerosis (any accepted biomarker of arterial stiffening at any arterial segment) or arterial remodeling (arterial hypertrophy (IMT) or artery lumen diameters). The following exclusion criteria were applied: epidemiological studies with a sample \<100 subjects, animal studies, reviews, systematic reviews, meta-analyses, comments/letters, studies using the assessment of Na intake and/or excretion of biomarkers other than Na (e.g., the ratio Na/K).

2.3. Selection of Studies and Data Extraction {#sec2dot3-nutrients-12-00005}
---------------------------------------------

Two reviewers screened the available titles, abstracts and keywords of all the available articles. Discrepancies were resolved after discussion. After agreement, full text screening was carried out. Qualitative and quantitative data from all included articles were extracted by both reviewers. The extracted data included specific details for study design, population characteristics, Na estimation method and outcomes related to Na and vascular damage. All units of Na are presented as mg (converted from mmol to mg, if necessary). Predefined variables (shown in [Table 1](#nutrients-12-00005-t001){ref-type="table"}, [Table 2](#nutrients-12-00005-t002){ref-type="table"}, [Table 3](#nutrients-12-00005-t003){ref-type="table"}, [Table 4](#nutrients-12-00005-t004){ref-type="table"} and [Table 5](#nutrients-12-00005-t005){ref-type="table"}) were extracted.

3. Results {#sec3-nutrients-12-00005}
==========

3.1. Number of Studies Screened and Selected {#sec3dot1-nutrients-12-00005}
--------------------------------------------

Eight hundred and twenty-five (825) citations were identified through a systematic search---of which, 782 were excluded on the basis of title/abstract. The most common exclusion criteria were: language (42), duplicates---same cohort (27), different research subject (516), not original articles (191), sample size \<100 subjects for observational studies only (6). Forty-three (43) articles were then assessed for eligibility and five were excluded due to irrelevant research subject and two due to different studying parameter (Na/K ratio). As a result, the number of articles that met the inclusion criteria and were included in this study were 36 ([Figure 1](#nutrients-12-00005-f001){ref-type="fig"}).

From a total of 36 studies included, 18 were observational and 18 were interventional studies. Detailed descriptive data for both observational and interventional studies are provided in [Table 1](#nutrients-12-00005-t001){ref-type="table"}, [Table 2](#nutrients-12-00005-t002){ref-type="table"}, [Table 3](#nutrients-12-00005-t003){ref-type="table"}, [Table 4](#nutrients-12-00005-t004){ref-type="table"} and [Table 5](#nutrients-12-00005-t005){ref-type="table"}.

3.2. Description of Studies {#sec3dot2-nutrients-12-00005}
---------------------------

Population description and exclusion criteria are reported in [Appendix B](#app2-nutrients-12-00005){ref-type="app"}.

### 3.2.1. Studies Investigating Arteriosclerosis (Arterial Stiffness) {#sec3dot2dot1-nutrients-12-00005}

Thirty-one (31) studies examining arteriosclerosis were identified---of which, 14 were observational \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005],[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B27-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B31-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\] and 17 were interventional \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B35-nutrients-12-00005],[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B38-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005],[@B44-nutrients-12-00005],[@B45-nutrients-12-00005],[@B46-nutrients-12-00005],[@B47-nutrients-12-00005],[@B48-nutrients-12-00005],[@B49-nutrients-12-00005]\].

#### Observational Studies

From the observational studies investigating arteriosclerosis, 11 out of 14 found a positive association between arterial stiffness biomarkers and dietary Na \[[@B15-nutrients-12-00005],[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\], one out of 14 found a J--shaped association \[[@B23-nutrients-12-00005]\], one out of 14 found an inverse association \[[@B16-nutrients-12-00005]\] and one out of 14 found no association \[[@B27-nutrients-12-00005]\] ([Table 1](#nutrients-12-00005-t001){ref-type="table"}). From the above 11 studies showing a positive association, nine of them measured vascular parameters at one time point \[[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\] and the remaining two studies evaluated arterial stiffness at two different time points \[[@B15-nutrients-12-00005],[@B28-nutrients-12-00005]\].

Heterogeneity in the assessment of arterial stiffness existed in the above 11 studies \[[@B15-nutrients-12-00005],[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\] due to: (a) various arterial stiffness biomarkers using different methodologies (four applanation tonometry \[[@B17-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005]\], six oscillometry \[[@B15-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\] and one b-mode ultrasonography \[[@B33-nutrients-12-00005]\]) at different arterial segments using various arterial stiffness biomarkers (five cfPWV \[[@B17-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B32-nutrients-12-00005]\], one aortic PWV other than cfPWV \[[@B29-nutrients-12-00005]\], four baPWV \[[@B15-nutrients-12-00005],[@B30-nutrients-12-00005],[@B31-nutrients-12-00005],[@B32-nutrients-12-00005]\] and one common carotid artery elasticity (Young's elastic modulus, stiffness index, arterial compliance) \[[@B33-nutrients-12-00005]\]) ([Table 1](#nutrients-12-00005-t001){ref-type="table"}); (b) various Na assessment methods (seven studies used 24h urine collection \[[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B34-nutrients-12-00005]\], two spot urine collections \[[@B28-nutrients-12-00005],[@B29-nutrients-12-00005]\] and two a combination of dietary methods \[[@B15-nutrients-12-00005],[@B33-nutrients-12-00005]\]); (c) different populations (five hypertensives \[[@B24-nutrients-12-00005],[@B25-nutrients-12-00005],[@B31-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005]\], one normotensive \[[@B26-nutrients-12-00005]\], one chronic kidney disease patient \[[@B28-nutrients-12-00005]\], three mixed populations \[[@B15-nutrients-12-00005],[@B22-nutrients-12-00005],[@B29-nutrients-12-00005]\] and one healthy subjects \[[@B30-nutrients-12-00005]\]) ([Table 1](#nutrients-12-00005-t001){ref-type="table"}).

Moreover, one out of the 11 studies showed that high Na excretion (mean: 2898 mg/day, range 2035.5--3588) is associated with cfPWV only when high Na excretion was combined with high renin--angiotensin--aldosterone system (RAAS) activity but not in the other groups (i.e., those with high Na and low RAAS, low Na and low RAAS, as well as low Na and high RAAS) \[[@B24-nutrients-12-00005]\].

Only seven out of these 11 studies adjusted the results for BP level \[[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B34-nutrients-12-00005]\] and only three of them persistently showed a positive association between arterial stiffness and Na after the adjustment \[[@B22-nutrients-12-00005],[@B31-nutrients-12-00005],[@B32-nutrients-12-00005]\].

In the one study that showed an inverse association between arterial stiffness and Na, the result persisted after adjustment for BP level \[[@B16-nutrients-12-00005]\].

Finally, salt sensitivity assessment was not conducted in any of the above 14 observational studies.

#### Interventional Studies

From the 17 interventional studies investigating the association between arteriosclerosis \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B35-nutrients-12-00005],[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B38-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005],[@B44-nutrients-12-00005],[@B45-nutrients-12-00005],[@B46-nutrients-12-00005],[@B47-nutrients-12-00005],[@B48-nutrients-12-00005],[@B49-nutrients-12-00005]\], seven of them showed statistically significant changes in arterial stiffness biomarkers after Na intake intervention \[[@B35-nutrients-12-00005],[@B37-nutrients-12-00005],[@B38-nutrients-12-00005],[@B44-nutrients-12-00005],[@B45-nutrients-12-00005],[@B46-nutrients-12-00005],[@B49-nutrients-12-00005]\]. On the contrary, 10 out of the 17 interventional studies found no changes in arterial stiffness biomarkers with various levels of Na intake during the intervention \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B36-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005],[@B47-nutrients-12-00005],[@B48-nutrients-12-00005]\] ([Table 2](#nutrients-12-00005-t002){ref-type="table"}).

In detail, three out of seven that found significant changes showed that increases in dietary Na were associated with an increase in arterial stiffness biomarkers \[[@B37-nutrients-12-00005],[@B43-nutrients-12-00005],[@B45-nutrients-12-00005]\] and four out of the seven showed that a reduction in dietary Na intake was associated with a decrease in arterial stiffness biomarkers \[[@B34-nutrients-12-00005],[@B36-nutrients-12-00005],[@B44-nutrients-12-00005]\] or even an increase in arterial elasticity biomarkers \[[@B48-nutrients-12-00005]\] ([Table 2](#nutrients-12-00005-t002){ref-type="table"}). Three of these seven studies found statistically significant changes only in specific intervention groups \[[@B36-nutrients-12-00005],[@B43-nutrients-12-00005],[@B45-nutrients-12-00005]\] (one study found that reduced Na excretion was associated with a decrease in cfPWV only in blacks, but not in whites and Asians \[[@B36-nutrients-12-00005]\]; one study found that high Na intake was associated with increased hfPWV only in salt-sensitive but not in salt-resistant participants \[[@B45-nutrients-12-00005]\]; one study found that a high-salt diet was associated with increased cfPWV only in middle-aged participants and not in young participants \[[@B43-nutrients-12-00005]\]).

In those seven studies finding statistically significant changes in PWV after high or low-Na diets \[[@B35-nutrients-12-00005],[@B37-nutrients-12-00005],[@B38-nutrients-12-00005],[@B44-nutrients-12-00005],[@B45-nutrients-12-00005],[@B46-nutrients-12-00005],[@B49-nutrients-12-00005]\], heterogeneity existed, regarding: (a) different methodologies used for arterial stiffness assessment (three b-mode ultrasonography \[[@B34-nutrients-12-00005],[@B45-nutrients-12-00005],[@B48-nutrients-12-00005]\], one oscillometry \[[@B44-nutrients-12-00005]\] and three tonometry \[[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B43-nutrients-12-00005]\]) and different arterial stiffness biomarkers assessed (four cfPWV \[[@B34-nutrients-12-00005],[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B43-nutrients-12-00005]\], one aortic PWV other than cfPWV \[[@B44-nutrients-12-00005]\], one heart-femoral (hfPWV) \[[@B45-nutrients-12-00005]\] and one arterial compliance \[[@B48-nutrients-12-00005]\]); (b) various methodologies used for Na assessment (four combination of dietary and urinary methods \[[@B34-nutrients-12-00005],[@B37-nutrients-12-00005],[@B44-nutrients-12-00005],[@B48-nutrients-12-00005]\], two 24h urine collection \[[@B36-nutrients-12-00005],[@B43-nutrients-12-00005]\] and one not available data \[[@B45-nutrients-12-00005]\]); (c) different duration of intervention period and (d) different populations (four in hypertensives or subjects with high normal BP \[[@B34-nutrients-12-00005],[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B48-nutrients-12-00005]\], two in normotensives \[[@B43-nutrients-12-00005],[@B44-nutrients-12-00005]\] and one in mixed populations (hypertensives and normotensives) \[[@B45-nutrients-12-00005]\]) ([Table 2](#nutrients-12-00005-t002){ref-type="table"}).

Of note, out of the seven studies that found statistically significant associations between Na and arterial stiffness biomarkers \[[@B35-nutrients-12-00005],[@B37-nutrients-12-00005],[@B38-nutrients-12-00005],[@B44-nutrients-12-00005],[@B45-nutrients-12-00005],[@B46-nutrients-12-00005],[@B49-nutrients-12-00005]\] only three studies adjusted the results for BP level \[[@B34-nutrients-12-00005],[@B43-nutrients-12-00005],[@B45-nutrients-12-00005]\]. One out of the three studies found that the statistically significant association between high-Na diet (6900 mg/day) and cfPWV in middle-aged adults was lost after correcting for the mean BP level \[[@B43-nutrients-12-00005]\]. Both other two studies found that their findings were independent from mean BP level \[[@B34-nutrients-12-00005],[@B45-nutrients-12-00005]\].

In the 10 studies that found no statistically significant changes in arterial stiffness biomarkers after different levels of Na intake \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B36-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005],[@B47-nutrients-12-00005],[@B48-nutrients-12-00005]\], heterogeneity existed, regarding: (a) different methodologies used for arterial stiffness assessment (seven tonometry \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005]\], one oscillometry \[[@B35-nutrients-12-00005]\], one plethysmography \[[@B46-nutrients-12-00005]\] and one diastolic blood pressure time decay method \[[@B47-nutrients-12-00005]\]) using similar arterial stiffness biomarkers assessed (eight cfPWV \[[@B22-nutrients-12-00005],[@B23-nutrients-12-00005],[@B36-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005]\], one baPWV \[[@B46-nutrients-12-00005]\] and one arterial compliance \[[@B47-nutrients-12-00005]\]); (b) various methodologies used for Na assessment (eight 24h urine collection \[[@B22-nutrients-12-00005],[@B39-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B42-nutrients-12-00005],[@B43-nutrients-12-00005],[@B47-nutrients-12-00005],[@B48-nutrients-12-00005]\] and two combination of dietary and urinary methods \[[@B18-nutrients-12-00005],[@B35-nutrients-12-00005]\]); (c) different duration of intervention period and (d) different population samples (six in hypertensives \[[@B17-nutrients-12-00005],[@B35-nutrients-12-00005],[@B38-nutrients-12-00005],[@B40-nutrients-12-00005],[@B41-nutrients-12-00005],[@B46-nutrients-12-00005]\] (one in overweight or obese hypertensives \[[@B35-nutrients-12-00005]\], one in hypertensives with chronic kidney disease patients \[[@B38-nutrients-12-00005]\], three in hypertensives \[[@B17-nutrients-12-00005],[@B41-nutrients-12-00005],[@B46-nutrients-12-00005]\], one in prehypertensives \[[@B40-nutrients-12-00005]\]), two in normotensives \[[@B18-nutrients-12-00005],[@B47-nutrients-12-00005]\], one in overweight or obese subjects \[[@B39-nutrients-12-00005]\] and one in women with preeclampsia or healthy pregnancy in the past \[[@B42-nutrients-12-00005]\])) ([Table 2](#nutrients-12-00005-t002){ref-type="table"}).

Finally, only two out of the 17 conducted salt sensitivity assessment \[[@B45-nutrients-12-00005],[@B46-nutrients-12-00005]\]. One out of the two studies revealed that the result was not statistically significant in the salt-resistant group, but only in the salt-sensitive group \[[@B45-nutrients-12-00005]\]. On the contrary, in the other study no significant differences between Na interventions and PWV were revealed for both salt-sensitive and salt-resistant participants, but salt-sensitive participants had higher baPWV at each time point of the intervention (baseline, low-Na diet, high-Na diet) \[[@B46-nutrients-12-00005]\].

### 3.2.2. Studies Investigating Arterial Remodeling {#sec3dot2dot2-nutrients-12-00005}

Nine studies examining arterial remodeling were identified \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B23-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005],[@B51-nutrients-12-00005]\]---of which, eight were observational \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B23-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\] ([Table 3](#nutrients-12-00005-t003){ref-type="table"}) and one was interventional \[[@B51-nutrients-12-00005]\] ([Table 4](#nutrients-12-00005-t004){ref-type="table"}).

#### Observational Studies

Out of the eight observational studies, six found positive \[[@B15-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\], one inverse \[[@B16-nutrients-12-00005]\] and one J-shaped associations \[[@B23-nutrients-12-00005]\] between cIMT and Na intake or excretion ([Table 3](#nutrients-12-00005-t003){ref-type="table"}). Out of the eight observational studies, seven measured the outcome at one time point (cross-sectional) \[[@B16-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B23-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\] and one study measured the outcome at two time points and examined the association between the change of cIMT and Na intake (prospective) as well \[[@B15-nutrients-12-00005]\] ([Table 3](#nutrients-12-00005-t003){ref-type="table"}). In the prospective study, although the cIMT was positively associated with Na intake, the change of cIMT during follow up was negatively associated with Na intake \[[@B15-nutrients-12-00005]\] ([Table 3](#nutrients-12-00005-t003){ref-type="table"}). Four out of the six studies that found positive associations between cIMT and Na adjusted their results for BP level \[[@B19-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\]: in two of them, the result was no more statistically significant after adjustment for BP \[[@B33-nutrients-12-00005],[@B49-nutrients-12-00005]\], in one of the studies, the result was marginally not significant after BP adjustment \[[@B50-nutrients-12-00005]\] and in the remaining one, the result was independent from BP \[[@B19-nutrients-12-00005]\]. The remaining two studies did not adjust their results for BP level \[[@B15-nutrients-12-00005],[@B20-nutrients-12-00005]\]. Finally, one out of the six studies that found a positive association implied a statistically significant correlation only with IMT at the carotid bifurcation but not at the common carotid artery \[[@B19-nutrients-12-00005]\].

Heterogeneity in the assessment of arterial remodeling existed in the above six studies due to: (a) different Na assessment methods (four dietary (one \[[@B19-nutrients-12-00005]\]) or a combination of dietary (three \[[@B15-nutrients-12-00005],[@B20-nutrients-12-00005],[@B33-nutrients-12-00005]\]) methods, two 24h urine collection \[[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\]) and (b) different studied populations (chronic diseases, age, comorbidities). All studies assessed cIMT as arterial remodeling biomarker via b-mode ultrasonography excluding from the measurement arterial segments with atheromatic plaques ([Table 3](#nutrients-12-00005-t003){ref-type="table"}).

The only study showing an inverse association was the only one conducted in purely normotensives as well as the only one using spot urine specimens for Na assessment \[[@B16-nutrients-12-00005]\]. Adjustment for BP was performed in this study and the result was independent from BP level \[[@B16-nutrients-12-00005]\]. The only study which showed a J-shaped association did not adjust the results for BP level \[[@B23-nutrients-12-00005]\].

Salt sensitivity assessment was not conducted in any of the eight studies.

#### Interventional Studies

The only interventional study that investigated the association between Na intake and arterial remodeling ([Table 4](#nutrients-12-00005-t004){ref-type="table"}) used brachial and carotid artery diameter as end point \[[@B51-nutrients-12-00005]\]. The brachial artery lumen increased after 8 weeks of a low-Na diet (mean ± SD: 1955 ± 220.8 mg/day) but no changes in the common carotid diameter were revealed. The findings were adjusted for BP levels \[[@B51-nutrients-12-00005]\]. Salt sensitivity assessment was not conducted \[[@B51-nutrients-12-00005]\] ([Table 4](#nutrients-12-00005-t004){ref-type="table"}).

### 3.2.3. Studies Investigating Atheromatosis {#sec3dot2dot3-nutrients-12-00005}

Only two observational studies examining atheromatosis were identified, showing conflicting results \[[@B19-nutrients-12-00005],[@B20-nutrients-12-00005]\] ([Table 5](#nutrients-12-00005-t005){ref-type="table"}). One study showed that higher Na intake (2050--2330 mg/day vs. 780--900 mg/day) is positively associated with the prevalence off carotid plaques \[[@B20-nutrients-12-00005]\], while the other study did not find a statistically significant association \[[@B19-nutrients-12-00005]\]. The two studies assessed Na via different ways (dietary and urinary) and used different populations (elderly females \[[@B20-nutrients-12-00005]\] as well as a general population \[[@B19-nutrients-12-00005]\]). Both studies examined carotid plaques via B-mode ultrasonography. One out of the two studies adjusted their results for BP levels and the result was independent from BP \[[@B19-nutrients-12-00005]\]. No study assessed salt sensitivity.

4. Discussion {#sec4-nutrients-12-00005}
=============

In the present study, we performed a systematic review of the literature to investigate the relationship between dietary Na intake with arterial function and structure using gold-standard non-invasive vascular biomarkers to measure arteriosclerosis, arterial remodeling and atheromatosis. The results of this systematic review indicate that: (i) although several studies have investigated the association of dietary Na with arterial stiffness, the evidence does not clearly support a clinically meaningful, direct and independent from BP effect of Na on the arterial wall to increase arterial stiffness; (ii) data regarding the association between dietary Na and arterial remodeling are limited, mostly suggesting a positive trend between dietary Na and arterial hypertrophy, but still inconclusive; (iii) data regarding the association between dietary Na and atheromatosis are scarce and the available studies present high heterogeneity.

4.1. Na and Arteriosclerosis {#sec4dot1-nutrients-12-00005}
----------------------------

Although 31 human studies have investigated the association between dietary Na and arteriosclerosis, the current data are inconclusive regarding a potential direct effect of Na on the arterial wall properties that accelerate the arterial stiffening process. Indeed, the majority of the studies (observational 11/14 and interventional 7/17) do imply the presence of a harmful effect of high Na intake \[[@B15-nutrients-12-00005],[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B32-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005],[@B38-nutrients-12-00005],[@B44-nutrients-12-00005],[@B46-nutrients-12-00005]\] or even benefits of low Na intake on arterial stiffening parameters \[[@B34-nutrients-12-00005],[@B36-nutrients-12-00005],[@B44-nutrients-12-00005],[@B48-nutrients-12-00005]\] (18 out of 31, 11 observational and seven interventional), in various populations \[[@B22-nutrients-12-00005],[@B26-nutrients-12-00005],[@B29-nutrients-12-00005],[@B34-nutrients-12-00005],[@B44-nutrients-12-00005]\], involving several different segments of the arterial tree \[[@B22-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B33-nutrients-12-00005],[@B45-nutrients-12-00005],[@B48-nutrients-12-00005]\], independently of the applied methodology, technology used \[[@B22-nutrients-12-00005],[@B29-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005]\]. However, most of these positive studies do not take into consideration the well-known effect of Na on BP increase \[[@B15-nutrients-12-00005],[@B24-nutrients-12-00005],[@B28-nutrients-12-00005],[@B29-nutrients-12-00005],[@B36-nutrients-12-00005],[@B37-nutrients-12-00005],[@B44-nutrients-12-00005]\]. Overall only 1/3 of the studies included in our analysis, and only 10 out of the 17 positive studies adjusted their findings for BP levels \[[@B17-nutrients-12-00005],[@B18-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B29-nutrients-12-00005],[@B30-nutrients-12-00005],[@B34-nutrients-12-00005],[@B35-nutrients-12-00005],[@B44-nutrients-12-00005],[@B46-nutrients-12-00005]\]. Even more interestingly, in more than half of them (six out of 10), the association between Na and indices of arteriosclerosis was lost after correcting for BP \[[@B25-nutrients-12-00005],[@B26-nutrients-12-00005],[@B30-nutrients-12-00005],[@B33-nutrients-12-00005],[@B34-nutrients-12-00005],[@B43-nutrients-12-00005]\]. Moreover, although salt sensitivity is a major factor modulating the effect of Na on BP (and therefore to arterial stiffness), only two \[[@B45-nutrients-12-00005],[@B46-nutrients-12-00005]\] out of the 31 studies evaluated this parameter and showed conflicting results. Indeed, there is evidence suggesting that a high-salt diet would increase BP in 17% of the subjects (salt sensitives), reduce BP in 11% (inverse salt sensitive) and not significantly affect BP in the remaining salt-resistant subjects \[[@B52-nutrients-12-00005]\]. Finally, just one study \[[@B23-nutrients-12-00005]\] showed a J-shaped association between Na and arteriosclerosis, mirroring the recent epidemiological data on the J-shaped association between Na and mortality.

A recent meta-analysis of randomized controlled trials, conducted by D' Elia and colleagues \[[@B53-nutrients-12-00005]\], being the first and the only one available on this topic so far, included 14 cohorts (all of them included in our work) and showed a statistically significant decrease by 2.84% in cfPWV after an average reduction of approximately 2 g (89.3 mmol) per day in Na intake independently from BP. In this meta-analysis, the authors excluded all the studies measuring other than the cfPWV, whereas we extended our systematic review to include all valid non-invasive indices of arterial stiffness including other segments of the arterial bed (such as the carotid artery and the lower limbs). Although our study is not applying a synthesis of quantitative data (as a meta-analysis), but uses only the qualitative characteristics of the selected studies, it is important to consider that the result of D' Elia et al. suggest poor, if any, clinical effects of Na on arterial stiffness. A reduction of PWV by 2.84% may not offer additional benefit in overall vascular health.

Taken all together, these data suggest that arterial stiffness can be reduced with a dietary intervention aiming at the reduction of dietary Na intake, but: (a) this reduction is modest (e.g., aortic stiffness of 10 m/s considered the high CVD risk cut-off level will be reduced to 9.8 m/s after a major reduction of Na by 2 g/day) with debatable clinical effect and (b) it is not established whether this lowering effect is mediated only by BP reduction or mediated by a direct effect on the arterial wall \[[@B54-nutrients-12-00005],[@B55-nutrients-12-00005]\].

Moreover, major questions seek suitable answers, since poor data regarding the role of salt sensitivity, the RAAS, age and race exist. The hypothesis that hyperactive RAAS leads to BP elevation and consequently arterial stiffening, as a result of BP rising in salt-sensitive subjects, cannot yet be rejected. In a single study, Kotliar et al. indicate a significant positive association between Na and PWV only in the group of participants who had high RAAS activity. However, the group with high Na and low RAAS activity did not show a significant association with PWV \[[@B24-nutrients-12-00005]\]. One of the studies suggested that only middle-aged and not young participants presented increased PWV after a high-salt diet \[[@B43-nutrients-12-00005]\]. However, in the study by Avolio et al., all of the age groups (children, young adults and middle-aged adults) decreased their PWV after reducing Na intake \[[@B44-nutrients-12-00005]\]. Finally, despite the fact that race has been shown to play a significant role in BP levels and salt sensitivity, indirectly affecting arterial stiffening, just one study addressed this issue and showed significant increases in PWV after Na supplementation only in black participants.

4.2. Na and Arterial Remodeling {#sec4dot2-nutrients-12-00005}
-------------------------------

Nine studies---all of them using B-mode ultrasonography---investigating the association between dietary Na and arterial remodeling were identified (eight observational \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B23-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\] and one interventional \[[@B51-nutrients-12-00005]\]). The majority of them (six out of the nine) implied a detrimental effect after high Na intake \[[@B15-nutrients-12-00005],[@B19-nutrients-12-00005],[@B20-nutrients-12-00005],[@B33-nutrients-12-00005],[@B49-nutrients-12-00005],[@B50-nutrients-12-00005]\] or even a beneficial effect after low Na intake \[[@B51-nutrients-12-00005]\] on arterial remodeling parameters (cIMT or artery diameters) independently of different methods used for Na assessment and various population groups (different diseases and comorbidities, age groups, etc.). In most cases, higher dietary Na intake was associated with higher cIMT in plaque-free arterial segments, mostly at the common carotid, suggesting arterial hypertrophy, but also carotid bulb \[[@B19-nutrients-12-00005]\] and brachial artery \[[@B51-nutrients-12-00005]\].

However, only three out of the nine studies included large population samples (\>1500 participants) \[[@B15-nutrients-12-00005],[@B16-nutrients-12-00005],[@B19-nutrients-12-00005]\] and their results were conflicting, since one of them found an inverse and BP-independent association between Na and cIMT but was the only one conducted in purely normotensives and assessed Na through spot urine specimens as well \[[@B16-nutrients-12-00005]\]. Probably, the best available study so far, the only interventional study published by Benetos et al., showed that independently from BP, increased Na intake only induced arterial remodeling in a muscular artery (brachial artery) but not in an elastic one (carotid artery), suggesting a diverging effect of Na in different arterial beds \[[@B51-nutrients-12-00005]\].

Most importantly, once more, the effect of potential confounding BP on arterial remodeling was not taken into consideration in 1/3 of the studies (three out of nine) \[[@B15-nutrients-12-00005],[@B20-nutrients-12-00005],[@B23-nutrients-12-00005]\]. Further, in two other studies \[[@B33-nutrients-12-00005],[@B49-nutrients-12-00005]\], the end point was actually mediated by BP increase. In conclusion, data on the association between dietary Na and arterial remodeling are limited, mostly suggesting a positive trend between dietary Na and arterial hypertrophy, but this is still inconclusive and conflicting. No study assessed salt sensitivity.

To our knowledge, the association between Na and arterial remodeling has not previously been subject to meta-analysis, and despite positive trends observed in the majority of studies, there is insufficient data to conclusively establish the relationship.

4.3. Na and Atheromatosis {#sec4dot3-nutrients-12-00005}
-------------------------

According to our systematic research, there are extremely limited data on the association between dietary Na and atheromatosis. Only two studies examined this association \[[@B19-nutrients-12-00005],[@B20-nutrients-12-00005]\]. Mazza et al., in a very small study \[[@B20-nutrients-12-00005]\], found that high dietary Na is associated with the increased prevalence of carotid plaques, whereas Dai et al., in a substantially larger study \[[@B19-nutrients-12-00005]\], suggested a non-significant association between dietary Na intake and carotid plaques. However, these studies presented heterogeneity in population samples (elderly females \[[@B20-nutrients-12-00005]\] and general population \[[@B19-nutrients-12-00005]\]), sample size (108 \[[@B20-nutrients-12-00005]\] and 3290 \[[@B19-nutrients-12-00005]\] participants) and Na assessment method (24h dietary recall and 7 day food record \[[@B20-nutrients-12-00005]\] and FFQ \[[@B19-nutrients-12-00005]\]). Moreover, the available studies regarding dietary Na and atheromatosis have not investigated the association between very low and very high levels of Na, and that might explain why a J-shaped trend has not been observed. Furthermore, beyond carotid arteries, plaque formation in other arterial segments that might offer an additive value in CVD prevention---such as the femoral arteries---has not been assessed in any of the available studies. In conclusion, there is not enough evidence to support a positive, negative or J-shaped association between dietary Na and arterial plaques and more studies investigating the association between larger ranges of Na intake/excretion and arterial plaques are needed.

4.4. Strengths and Limitations {#sec4dot4-nutrients-12-00005}
------------------------------

Major strengths of our study are: (i) the novel concept of investigating the effect of dietary Na on SAD, including all the major pathogenetic mechanisms (arteriosclerosis, arterial remodeling & atheromatosis); (ii) the systematic nature of this review in order to compare and dispose all the available international literature on this specific topic; (iii) the design of our study, including clinical trials and evidence from observational studies in order to investigate the short- and long-term effects of different levels of Na intake on SAD. A limitation of our study is the absence of a quantitative analysis of the extracted data (meta-analysis), which could lead to a clearer view of the topic.

5. Conclusions {#sec5-nutrients-12-00005}
==============

In conclusion, there is not yet enough evidence to support a direct and causal association between Na and each of the major types of SAD, even in the most widely studied case of arteriosclerosis (arterial stiffening). The available data derive mostly from small, heterogeneous, not well-designed studies. Especially in the case of arterial remodeling and atheromatosis, both common and clinically relevant types of structural arterial damage have scarcely been investigated in relation to Na intake or excretion. One of the dominant issues is the heterogeneity of the studies in Na assessment method. Precise quantification of Na intake is difficult and despite the fact that only the 24h urine collection is regarded as a gold standard, based on the knowledge that approximately 90% of Na intake is excreted through urine, other dietary or spot urinary methods are commonly used in studies. Several disadvantages of the above mentioned studies have been described, such as underreporting, equations suitable only for specific population groups, different recipes, etc., leading to inaccurate measurements. Finally, many studies included in our analysis do not address the cardinal effect of Na on BP and almost all of them neglect the role of salt-sensitivity. Future studies using novel diagnostic tests for individuals' salt sensitivity assessment are needed to clarify the role of dietary Na to SAD \[[@B56-nutrients-12-00005]\]. More well-designed interventional studies are needed in order to resolve all the remaining controversies.
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Arteriosclerosis---Observational Studies

cfPWV

1\. Observational Cross-Sectional Studies

Author (year)

Population Description

Exclusion Criteria

Polónia, J. (2006)

essential hypertensives, recent stroke or healthy university students

urine sample not meeting the required quality criteria

García-Ortiz, L. (2012)

primary care patients aged 30--80

cardiovascular and/or cerebrovascular disease

Kotliar, C. (2014)

essential hypertensives, aged 30 to 70

abnormal renal function; volume or electrolyte alterations; diabetes mellitus; history of renal disease, ischemic heart disease, stroke; loss of data; counter indication for the drug washout; use of corticoids or nonsteroidal anti-inflammatory drugs during the study

Polonia, J. (2016)

hypertensive adults

secondary hypertension, previous cardiovascular events history; estimated glomerular filtration rate \>50 mL/min/1.73

Strauss, M. (2018)

normotensive adults

previously diagnosed chronic illness (self-reported); use of anti-hypertensive drugs or other chronic diseases; diabetes mellitus; HIV infected; microalbuminuria\>30 mg/mL; pregnancy or lactation

Triantafyllou, A. (2018)

newly diagnosed & never-treated hypertensives---healthy individuals admitted for regular check-up

previously treated with anti-hypertensive drugs; use of any kind of drugs; other known health problems; secondary causes of hypertension; other comorbidities (e.g., diabetes mellitus, CVD)

2\. Observational Studies with Follow up (\>1 Time Points)

Nerbass, F.B. (2015)

adults in CKD stage 3

solid organ transplant or terminally illness

Aortic PWV Other Than cfPWV

Siriopol, D. (2018)

hypertensive & normotensive Romanian adults

use of diuretic treatment; CKD; missing values for the variables of interest

baPWV

1\. Observational Cross-Sectional Studies

Sonoda, H. (2012)

healthy subjects

heart failure; valvular heart disease; atrial fibrillation; peripheral artery disease

Lee, S.K. (2015)

non-hypertensive subjects, with no use of anti-hypertensive drugs

age \>70 years; preexisting CVD including significant valvular heart diseases and arrhythmia; chronic renal disease or a serum creatinine level \>1.5 mg/dL; unavailable urinary Na data, inadequate data of tissue Doppler echocardiography, carotid ultrasound, or baPWV; ejection fraction of \<55% after echocardiography

Sun, N. (2015)

newly diagnosed hypertensives, untreated hypertensives or patients with a 1 to 5 year history of hypertensives who had stopped taking anti-hypertensive drugs for 1 month

use of anti-hypertensive drugs; secondary hypertension; hypertensive emergency; hypertensive urgency; acute coronary syndrome; severe arrhythmias; DM; stroke; CKD

Han, W. (2017)

hypertensive adults

any secondary cause of hypertension; hypertension emergencies; serious arrhythmia; peripheral arterial disease; heart failure; impaired renal function with plasma creatinine ≥150 μmol/L; rheumatic & autoimmune diseases; malignancies

2\. Observational Studies with Follow up (\>1 Time Points)

Jung, S. (2019)

adults aged \>40

history of heart disease, stroke, and/or cancer; anti-hypertensive drugs; diabetes mellitus; dyslipidemia; implausible dietary intake reported (\< 500 or \> 4000 kcal/day); missing general characteristic data from the baseline visit

Common Carotid Arterial Elasticity (Young's Elastic Modulus, Stiffness Index, Arterial Compliance)

Ferreira-Sae, M.C. (2011)

hypertensive adults

age \<18 years; neoplastic disease; secondary hypertension

Arteriosclerosis---Interventional studies

cfPWV

Seals, D.R. (2001)

postmenopausal women, ≥50 years, high normal SBP or Stage 1 hypertension

anti-hypertensive drugs; other chronic disease; low-Na diet or regular exercise during the preceding 2 years; smoking

Dickinson, K.M. (2009)

overweight/obese, mild hypertensive adults

metabolic disease; CVD; SBP \>160 mm Hg at screening; significant weight loss in the preceding 6 months (\>2 kg); BMI \< 27 or \> 40; use of anti-hypertensive drugs

He, F.J. (2009)

hypertensive adults

anti-hypertensive drugs; secondary cause of hypertension; impaired renal function; previous stroke; ischemic heart disease; heart failure; diabetes mellitus; malignancy; liver disease; pregnancy or lactation or on oral contraceptive pills

Pimenta, E. (2009)

resistant hypertensive adults on stable anti-hypertensive drugs

history of atherosclerotic disease (in the previous 6 months); congestive heart failure; diabetes mellitus on insulin treatment; office blood pressure \> 160/100 mm Hg

Todd, A.S. (2010)

Pre-hypertensive or hypertensive, non-obese adults or in anti-hypertensive drugs

age \>65; smoking; history of CVD or diabetes mellitus or renal disease

Todd, A.S. (2012)

normotensives, non-obese adults

age \>65; antihypertensive medication; smoking; history of cardiovascular disease or diabetes mellitus or renal disease

McMahon, E.J. (2013)

hypertensive adult patients with stage 3 or 4 CKD (GFR 15--59 mL/min per 1.73 m

2

), non-dialyzed, non-transplanted

salt-wasting CKD, pregnant or breastfeeding, current prescription of medications providing 0.20 mmol sodium per day, life expectancy,6 months, current involvement in another intervention study, or insufficient mental or physical capacity to adhere to the study protocol.

Dickinson, K.M. (2014)

overweight or obese subjects

diabetes mellitus; dyslipidemia; inflammatory bowel disease; pulmonary disease or vasculitis

Gijsbers, L. (2015)

untreated prehypertensives, aged 40--80

smoking; diabetes mellitus, CVD; gastrointestinal, liver or renal diseases; BMI \> 40; use of drugs known to affect the cardiovascular system; use of nutritional supplements, an energy-restricted or medically prescribed diet; unstable body weight in past 2 months; alcohol use over 21 (women) or 28 (men) consumptions/week; pregnancy or lactation

Suckling, F.J. (2016)

untreated hypertensive adults with diet-controlled type 2 diabetes mellitus or impaired glucose tolerance

any secondary causes of hypertension, impaired renal function (plasma creatinine \>150 μmol), uncontrolled heart failure, ischemic heart disease, previous stroke, active malignancy or liver disease, pregnancy, breast feeding, or oral contraceptive drugs

van der Graaf, A.M. (2016)

women with history of preeclampsia or history of healthy former pregnancy

renal disease; diabetes mellitus or a history of gestational diabetes; obesity; use of anti-hypertensive drugs; pregnancy; lactation; postmenopausal status; use of oral contraceptives

Muth, B.J. (2017)

healthy, normotensive adults

history of hypertension; CVD; malignancy; diabetes mellitus; renal impairment; obesity; smoking

Aortic PWV (Other than cfPWV)

Avolio, A.P. (1986)

healthy normotensive adults & children

N/AV

hfPWV

Rhee, M.Y. (2016)

normotensive & hypertensive adults

stage 2 and 3 hypertension; secondary hypertension; angina pectoris; myocardial infarction; congestive cardiac failure; stroke; diabetes mellitus; CKD

baPWV

Wang, Y. (2015)

mild hypertensive adults

stage 2 hypertension; history of clinical CVD; CKD; diabetes mellitus; use of anti-hypertensive drugs; high alcohol intake

Arterial Elasticity (Arterial Compliance)

Creager, M.A. (1991)

normotensive men

hematologic, renal, or hepatic dysfunction

Gates, P.E. (2004)

hypertensive adults (stage 1), older than 50

use of anti-hypertensive drugs; abnormal blood chemistry; positive ECG-monitored exercise test; ankle--brachial index \> 0.9; presence of plaque on ultrasound interrogation of the carotid and femoral arteries; smoking for previous 2 years; BMI \< 35; consumption of a low-Na diet; not in postmenopausal if female (amenorrheic for at least 2 years)

Arterial Remodeling---Observational Studies

cIMT

1\. Observational Cross-Sectional Studies

Ferreira-Sae, M.C. (2011)

hypertensive adults

age \<18 years; neoplastic disease; secondary hypertension

Njoroge, J.N. (2011)

overweight or obese, physically inactive adults

diabetes mellitus; anti-hypertensive drugs or average baseline SBP of ≥140 or DBP ≥ 90 mmHg; cholesterol lowering or anti-psychotic or vasoactive drugs; use of vasoactive devices; pregnancy or lactation

García-Ortiz, L. (2012)

primary care patients aged 30--80

cardiovascular and/or cerebrovascular disease

Lee, S.K. (2015)

non-hypertensive individuals, with no use of anti-hypertensive drugs

age \>70 years; preexisting CVD including significant valvular heart diseases and arrhythmia; chronic renal disease or a serum creatinine level \> 1.5 mg/dL; unavailable urinary Na data, inadequate data of tissue Doppler echocardiography, carotid ultrasound, or baPWV; ejection fraction of \<55% after echocardiography

Ustundag, S. (2015)

ambulatory adult patients, in stage 2--4 CKD

BMI \< 35 kg/m2; diabetes mellitus; salt-losing nephropathy or history of malignancy or cardio-cerebrovascular disease or any acute disease

Dai, X.W. (2016)

Asian adults, via subject referral and community advertisement

hospital-confirmed diabetes mellitus; CVD; renal failure; CKD; cancer

Mazza, E. (2018)

adults aged ≥65, not suffering from any debilitating diseases

history of CVD or thyroid dysfunction or excessive alcohol consumption; use of dietary supplements & psychotropic drugs

2\. Observational studies with follow up (\>1 time points)

Jung, S. (2019)

adults aged \>40

history of heart disease, stroke, and/or cancer; anti-hypertensive drugs; diabetes mellitus; dyslipidemia; implausible dietary intake reported (\< 500 or \> 4000 kcal/day); missing general characteristic data from the baseline visit

Arterial Remodeling---Interventional Studies

Right Branchial Artery & Common Carotid Artery Diameter

Benetos, A. (1992)

actively working, mild to moderate hypertensive adults

cardiac, neurologic or renal involvement or arteriosclerosis obliterans of the lower limbs

Atheromatosis---Observational Studies

Carotid Plaques

Dai, X.W. (2016)

Asian adults, via subject referral and community advertisement

hospital-confirmed diabetes mellitus; CVD; renal failure; CKD; cancer

Mazza, E. (2018)

adults aged ≥65, not suffering from any debilitating diseases

history of CVD or thyroid dysfunction or excessive alcohol consumption; use of dietary supplements & psychotropic drugs

Abbreviations: CKD: chronic kidney disease; CVD: cardiovascular disease; BMI: body mass index; Na: Sodium; N/AV: not available.
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###### 

Descriptive characteristics of observational studies regarding arteriosclerosis.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ARTERIOSCLEROSIS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  ------------------------------------------------------------------------------------------------------------ -------------- ------------------ -------------------------------------------------------------------------------------------------------------------------------- ----------------- --------- ---------- ------- ---------------------------- -------------------------------------------------------------------------- ----------------------------------------------------- ------------------------- --------------------------------- ---------
  **cfPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **1. Observational Cross-Sectional Studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **Author (Year)**                                                                                            **Country**    **Study Design**   **Population Description**                                                                                                       **FU (Years)**    **Sex**   **Race**   **N**   **Age (Years, Mean ± SD)**   **Na Estimation Method**                                                   **Na Intake/Excretion (mg/d)**                        **Vascular Assessment**   **Results**                       

  Polónia, J. (2006) \[[@B22-nutrients-12-00005]\]                                                             Portugal       c-sect             essential HT, recent stroke or healthy university students                                                                       \-                M/F       Mixed      426     50 ± 22                      24hU                                                                       Total: 4646 ± 1472                                    tonometry                 \+ \*\*                           

  García-Ortiz, L. (2012) \[[@B23-nutrients-12-00005]\]                                                        Spain          c-sect             primary care patients aged 30--80                                                                                                \-                M/F       N/AV       351     54.8 ± 11.7                  FFQ                                                                        Total: 3180 ± 1250\                                   tonometry                 J-shaped curve                    
                                                                                                                                                                                                                                                                                                                                                                                                                                         Q1:1800 ± 390\                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                         Q2: 2650 ± 200\                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                         Q3: 3440 ± 270                                                                                                    

  Kotliar, C. (2014) \[[@B24-nutrients-12-00005]\]                                                             Argentina      c-sect             essential HT, aged 30 to 70                                                                                                      \-                M/F       N/AV       300     48.7 ± 14.6                  24hU                                                                       \(a\) low Na-low RAAS: 913.1 (747.5--1035)            tonometry                 ≠                                 

  \(b\) low Na-high RAAS: 690 (602.6--740.6)                                                                   ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  \(c\) High-Na-low RAAS: 2610.5 (1745.7--3604.1)                                                              ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  \(d\) high-Na-high RAAS: 2898 (2035.5--3588)                                                                 \+ \*                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Polonia, J. (2016) \[[@B25-nutrients-12-00005]\]                                                             Portugal       retrosp            HT adults                                                                                                                        7.2 (0.5--11.1)   M/F       White      608     54.1 ± 14.3                  24hU                                                                       4793.2 ± 1821.6                                       tonometry                 \+ \*                             

  Strauss, M. (2018) \[[@B26-nutrients-12-00005]\]                                                             South Africa   prosp              NT adults                                                                                                                        \-                M/F       Mixed      693     24.8 ± 3.01                  24hU                                                                       2967 (984.4--7613)                                    tonometry                 total                             \+ \*\*

  black                                                                                                        \+ \*                                                                                                                                                                                                                                                                                                                                                                                                                                       

  white                                                                                                        ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Triantafyllou, A. (2018) \[[@B27-nutrients-12-00005]\]                                                       Greece         c-sect             untreated HT---healthy individuals                                                                                               \-                M/F       White      197     43.7 ± 12.1                  24hU                                                                       True HT: 3348.8 (2251.7--4595.4)\                     tonometry                 ≠                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                         Intermediated HT phenotypes: 3128 (1902.1--4312.5)\                                                               
                                                                                                                                                                                                                                                                                                                                                                                                                                         NT: 2732.4 (1630.7--4312.5)                                                                                       

  **2. Observational Studies with Follow Up (\>1 Time Points)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  **Author (Year)**                                                                                            **Country**    **Study Design**   **Population Description**                                                                                                       **FU (Years)**    **Sex**   **Race**   **N**   **Age (Years, Mean ± SD)**   **Na Estimation Method**                                                   **Na Intake/Excretion (mg/d)**                        **Vascular Assessment**   **Results**                       

  Nerbass, F.B. (2015) \[[@B28-nutrients-12-00005]\]                                                           UK             prosp              adults in CKD stage 3                                                                                                            1                 M/F       N/AV       1607    72.6 ± 9.0                   Spot urine collections and Nerbass equation to estimate 24h Na excretion   baseline: 2599 ± 782\                                 oscillometry              **cfPWV** (at both time points)   
                                                                                                                                                                                                                                                                                                                                                                                                                                         follow-up: 2576 ± 782                                                                                             

  Na \<2300 mg                                                                                                 \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Na \>2300 mg                                                                                                 ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **ΔcfPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Unchanged Na                                                                                                 ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Decreased Na                                                                                                 ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Increased Na                                                                                                 \+ \*                                                                                                                                                                                                                                                                                                                                                                                                                                       

  **Aortic PWV Other than cfPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Siriopol, D. (2018) \[[@B29-nutrients-12-00005]\]                                                            Romania        prosp              HT and NT Romanian adults                                                                                                        \-                M/F       White      1599    47.3 ± 17.1                  Morning spot urine sample + Kawasaki equation                              4816.2 ± 1550.2                                       oscillometry              NT                                \+ \*\*

  HT                                                                                                           \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **baPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  **1. Observational Cross-Sectional Studies**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Sonoda, H. (2012) \[[@B30-nutrients-12-00005]\]                                                              Japan          c-sect             healthy subjects                                                                                                                 \-                M/F       Asian      911     61.3 ± 8.5                   24hU                                                                       720 ± 200 (mg /day/10 kg)                             oscillometry              \+ \*\*                           

  Lee, S.K. (2015) \[[@B16-nutrients-12-00005]\]                                                               Korea          c-sect             non-HT subjects, with no use of anti-HT drugs                                                                                    \-                M/F       Asian      1586    tertile 1: 52.1 ± 5.5\       Second morning void and Tanaka's equation to convert to 24hU               3588 ± 782                                            plethysmography           − \*\*                            
                                                                                                                                                                                                                                                                                                                                 tertile 2: 53.0 ± 6.0\                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                 tertile 3: 52.6 ± 5.5                                                                                                                                                                                                     

  Sun, N. (2015) \[[@B31-nutrients-12-00005]\]                                                                 China          c-sect             newly diagnosed HT, untreated HT or patients with a 1 to 5 year history of HT who had stopped taking anti-HT drugs for 1 month   \-                M/F       N/AV       341     Group A: 59.3 + 13.4\        24hU                                                                       Total: 3507.5 ± 1577.8\                               oscillometry              \+ \*                             
                                                                                                                                                                                                                                                                                                                                 Group B: 56.1 + 15.5\                                                                                   Group A: 1807.8 ± 411.7\                                                                                          
                                                                                                                                                                                                                                                                                                                                 Group C: 57.6 + 14.2                                                                                    Group B: 3374.1 ± 618.7\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                         Group C: 5858.1 ± 961.4                                                                                           

  **Author (year)**                                                                                            **Country**    **Study Design**   **Population Description**                                                                                                       **FU (years)**    **Sex**   **Race**   **N**   **Ag (Years, Mean ± SD)**    **Na Estimation Method**                                                   **Na Intake/Excretion (mg/d)**                        **Vascular Assessment**   **Results**                       

  Han, W. (2017) \[[@B32-nutrients-12-00005]\]                                                                 China          c-sect             HT adults                                                                                                                        \-                M/F       N/AV       431     Group A: 54.5 ± 12.9\        24hU                                                                       Total: 3831.8 ± 1.610,\                               oscillometry              \+ \*                             
                                                                                                                                                                                                                                                                                                                                 Group B: 52.9 ± 12.6\                                                                                   Group A: 1768.7 ± 464.6\                                                                                          
                                                                                                                                                                                                                                                                                                                                 Group C: 50.9 ± 11.4                                                                                    Group B: 3371.8 ± 650.9\                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                         Group C: 5947.8 ± 1069.5                                                                                          

  **2. Observational Studies with Follow Up (\>1 Time Points)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Jung, S. (2019) \[[@B15-nutrients-12-00005]\]                                                                South Korea    prosp              adults aged \>40                                                                                                                 5.3±1.0           M/F       Mixed      2145    59.9 ± 9.1                   FFQ and 3 day diet record                                                  2538 ± 1416                                           oscillometry              **baPWV**                         

  Na baseline                                                                                                  \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Na average of three visits                                                                                   \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **ΔbaPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Na baseline                                                                                                  \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Na average of three visits                                                                                   \+ \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Common Carotid Arterial Elasticity (Young's Elastic Modulus, Stiffness Index, and Arterial Compliance)**                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Ferreira-Sae, M.C. (2011) \[[@B33-nutrients-12-00005]\]                                                      Brazil         c-sect             HT adults                                                                                                                        \-                M/F       N/AV       134     58 ± 1                       1\. FFQ\                                                                   Na intake/d: 5520 ± 290\                              B-mode US                 Young's elastic modulus           \+ \*\*
                                                                                                                                                                                                                                                                                                                                                              2. 24h recall\                                                              FFQ: 1450 ± 180\                                                                                                 
                                                                                                                                                                                                                                                                                                                                                              3. discretionary Na intake ^1^                                              24h recall: 940 ± 70\                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                          Discretionary Na: 3130 ± 190                                                                                     

  stiffness index                                                                                              ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           

  arterial compliance                                                                                          ≠                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The mmol of Na intake/excretion values were converted to mg. If available, results presented come from adjusted models. Abbreviations: Na: sodium; 24hU: 24h urine collection; cfPWV: carotid--femoral pulse wave velocity; baPWV: brachial--ankle pulse wave velocity; HT: hypertensives; NT: normotensives; anti-HT: antihypertensive; c-sect: cross-sectional; prosp: prospective; retrosp: retrospective; FFQ: food frequency questionnaire; FU: follow up; M/F: males and females; N/AV: not available; RAAS: renin--angiotensin--aldosterone system; CKD: chronic kidney disease; US: ultrasonography; +: positive association; -: negative association; ≠: no statistically significant association; \*: *p* \< 0.05; \*\*: *p* \< 0.01. ^1^ number of 1 kg packages of salt consumed/month/person.

nutrients-12-00005-t002_Table 2

###### 

Descriptive characteristics of interventional studies regarding arteriosclerosis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ARTERIOSCLEROSIS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ---------------------------------------------------------- ------------------------------- ---------------------------- --------------------------------------------------------------------------- --------- ---------- ------- ----------------------------------- --------------------------------------- ------------------------------------------------------------------------------------- ---------------------------------------------- --------------------------------------------------------------------------- -------------------------------------------- ----------------------------- -------------------- ---
  **cfPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Author**                                                 **Country**                     **Study Design**             **Population Description**                                                  **Sex**   **Race**   **N**   **Age (Years, Mean ± SD)**          **Intervention Duration (Weeks)**       **Type of Diet**                                                                      **Na Estimation Method**                       **Na Intake/Excretion (mg/d)**                                              **Vascular Assessment**                      **Results**                                        

  **Intervention Groups**                                    **cfPWV Change (m/s)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Seals, D.R. (2001) \[[@B34-nutrients-12-00005]\]           USA                             RCT                          postmenopausal women, ≥50 years, high normal SBP or Stage 1 HTN             F         Mixed      17      65 ± 10                             13                                      LS \< 2400 mg                                                                         24hU & food records                            Urinary Na excretion Preint_restr: 2852 ± 1058 Postintn_restr:1978 ± 736\   US                                           LS vs. baseline               −0.24 \*             
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Dietary Na intake\                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Preint_restr: 2685 ± 559\                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Postint_restr:1421 ± 512                                                                                                                                                    

  Dickinson, K.M. (2009) \[[@B35-nutrients-12-00005]\]       Australia                       cross-over RCT               OW/OB, mild HT adults                                                       M/F       N/AV       29      52.7 ± 6.0                          4 (2 weeks × two diets)                 Usual Na diet: 3450 mg Na/d vs. LS diet: 1150 mg Na/d                                 Three-day weighed food records & 24hU          Urinary method                                                              oscillometry                                 LS vs. Usual Na               ≠                    

  Baseline                                                   3553.5 ± 1568.6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Usual Na                                                   3594.9 ± 1304.1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  LS                                                         1474.3 ± 949.9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  He, F.J. (2009) \[[@B36-nutrients-12-00005]\]              UK                              cross-over dbRCT             HT adults                                                                   M/F       Mixed      169     All: 50 ± 11\                       12                                      9 Na tablets (×230 mg)/d & 9 placebo tablets/d. (remained on LS diet: 2000 mg Na/d)   24hU                                           Total                                                                       3013 ± 1150                                  tonometry                     From Na to placebo   
                                                                                                                                                                                                                                   Blacks: 50 ± 9\                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                   Whites: 52 ± 12\                                                                                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                   Asians: 47 ± 10                                                                                                                                                                                                                                                                                                                                                                              

  Total                                                      −0.40 \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Blacks                                                     3036 ± 1058                     Blacks                       −0.50 \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Whites                                                     2921 ± 1173                     Whites                       ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Asians                                                     3174 ± 1311                     Asians                       ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Pimenta, E. (2009) \[[@B17-nutrients-12-00005]\]           USA                             cross-over RCT               resistant HT adults on a stable anti-HT drug                                M/F       Mixed      12      55.5 ± 9.4                          2 (1 week × two diets)                  LS diet: 1495 mg Na/d vs. HS diet: suppl. \>5750 mg Na/d                              24hU                                           Baseline: 4478.1 ± 1577.8\                                                  tonometry                                    From HS to LS ≠                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                    LS diet: 1060.3 ± 616.4 vs. HS diet: 5800.6 ± 1485.8                                                                                                                        

  Todd, A.S. (2010) \[[@B37-nutrients-12-00005]\]            New Zealand                     cross-over sbRCT             PHT or HT, NOB adults or on anti-HT drugs                                   M/F       Mixed      33      51.8 ± 7.6                          12                                      (500 mL tomato juice + LS diet/day) (A) 0 + 1380 mg (B) 2070 + 1380 mg\               Morning spot urine samples & dietary recalls   Na intake                                                                   tonometry                                    B vs. A                       \+ 0.39 \*\*         
                                                                                                                                                                                                                                                                                                               (C) 3220 + 1380 mg                                                                                                                                                                                                                                                                                               

  Usual diet                                                 2607 ± 1289                     C vs. A                      \+ 0.35 \*\*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  A                                                          1254 ± 397                      B vs. C                      ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  B                                                          1357 ± 486                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  C                                                          1306 ± 335                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Todd, A.S. (2012) \[[@B18-nutrients-12-00005]\]            New Zealand/Australia           cross-over sbRCT             NT, NOB adults                                                              M/F       N/AV       23      43.7 (24--61)                       12                                      (500 mL tomato juice + LS diet/day)\                                                  Morning spot urine samples & dietary recalls   Pre-baseline:                                                               2410.4                                       tonometry                     B vs. A              ≠
                                                                                                                                                                                                                                                                                                               (A) 0 + 1380 mg\                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                               (B) 2070 + 1380 mg\                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                               (C) 3220 + 1380 mg                                                                                                                                                                                                                                                                                               

  After intervention (Na intake + Na tomato juice)           C vs. A                         ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  A                                                          0 + 1232.8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  B                                                          2070 + 1207.5                   B vs. C                      ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  C                                                          3220 + 1140.8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  McMahon, E.J. (2013) \[[@B38-nutrients-12-00005]\]         Australia                       cross-over dbRCT             HT adults, with stage 3 or 4 CKD                                            M/F       N/AV       20      68.5 ± 11                           4 (2 weeks × two diets)                 HS diet: 4140--4600 mg Na/d\                                                          24hU                                           LS: 1725 (1334--2576) vs. HS: 3864 (3358--5037)                             tonometry                                    LS vs. HS                     ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                               LS diet: 1380--1840 mg Na/d                                                                                                                                                                                                                                                                                      

  Dickinson, K.M. (2014) \[[@B39-nutrients-12-00005]\]       Australia                       cross-over sbRCT             OW or OB subjects                                                           M/F       N/AV       25      N/AV                                6                                       LS diet: 2400 mg/d\                                                                   24hU                                           baseline: 2761 ± 1031\                                                      tonometry                                    LS vs. US                     ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 Usual Na diet: 1729 ± 627\                                                                                                                                                  
                                                                                                                                                                                                                                                                                                               Usual Na diet: 3600 mg/d                                                                                                             LS diet: 1799 ± 497                                                                                                                                                         

  Gijsbers, L. (2015) \[[@B40-nutrients-12-00005]\]          the Netherlands                 cross-over RCT               untreated (P)HT, aged 40--80                                                M/F       White      36      65.8 (47--80)                       4                                       Na suppl: 3000 mg/d\                                                                  24hU                                           Baseline: 3535.1\                                                           tonometry                                    Na suppl. vs. placebo         ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 Na suppl.: 4666.7 ± 1260.4 vs. Placebo: 2417.3 ± 913.1                                                                                                                      
                                                                                                                                                                                                                                                                                                               placebo                                                                                                                                                                                                                                                                                                          

  Suckling, F.J. (2016) \[[@B41-nutrients-12-00005]\]        United Kingdom                  Cross-over dbRCT             untreated HT adults                                                         M/F       Mixed      46      58 ± 1                              12 (6 weeks × two diets)                9 Na tablets (×230 mg)/d\                                                             24hU                                           Na diet: 3797.3 ± 207 vs. Placebo: 2681.8 ± 218.5                           tonometry                                    Na diet vs. placebo           ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                                                                                                                                                                                             
                                                                                                                                                                                                                                                                                                               9 placebo tablets/d.                                                                                                                                                                                                                                                                                             

  van der Graaf, A.M. (2016) \[[@B42-nutrients-12-00005]\]   the Netherlands                 cross-over RCT               women with history of preeclampsia or history of healthy former pregnancy   F         N/AV       36      36 ± 5                              2                                       LS diet: 1150 mg/d\                                                                   24hU                                           NT pregnancy history group:\                                                tonometry                                    LS vs. HS (in either group)   ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 LS: 897 ± 322\                                                                                                                                                              
                                                                                                                                                                                                                                                                                                               HS diet: 4600 mg/d                                                                                                                   HS: 5083 ± 1472\                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Preeclamptic pregnancy history group:\                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                                                                                                                                    LS: 1035 ± 529\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                                                                                                                    HS: 5934 ± 1978                                                                                                                                                             

  Muth, B.J. (2017) \[[@B43-nutrients-12-00005]\]            USA                             cross-over RCT               healthy, NT adults                                                          M/F       N/AV       85      Young: 27 ± 1 Middle-aged: 52 ± 1   2                                       LS diet: 460 mg/d\                                                                    24hU                                           \* LS diet (young & middle aged): 690\                                      tonometry                                    middle aged                   +0.60 \*\*           
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 HS diet (young & middle-aged): 5405\                                                                                                                                        
                                                                                                                                                                                                                                                                                                               HS diet:6900 mg/d                                                                                                                    \* Approximately from diagram                                                                                                                                               

  young                                                      ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **Aortic PWV (Other than cfPWV)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **Author**                                                 **Country**                     **Study Design**             **Population Description**                                                  **Sex**   **Race**   **N**   **Age(Years, Mean ± SD)**           **Intervention Duration**               **Type of Diet**                                                                      **Na Estimation Method**                       **Na Intake/Excretion (mg/d)**                                              **Vascular Assessment**                      **Results**                                        

  **Intervention groups**                                    **PWV Change (%)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Avolio AP. (1986) \[[@B44-nutrients-12-00005]\]            Australia                       RCT                          healthy NT adults and children                                              M/F       N/AV       114     Group 1: Control: 10.8 ± 1.9\       24.8±2.5 months (8 months to 5 years)   N/AV                                                                                  24hU & diet questionnaire                      Na excretion:\                                                              oscillometry                                 Group 1 leg                   −11.2 \*             
                                                                                                                                                                                                                                   LS: 10.4 ± 2.5\                                                                                                                                                                                                  Control group: N/AV\                                                                                                                                                        
                                                                                                                                                                                                                                   Group 2: Control: 39.4 ± 1.7\                                                                                                                                                                                    Group 1: 1564\                                                                                                                                                              
                                                                                                                                                                                                                                   LS: 39.8 ± 1.6\                                                                                                                                                                                                  Group 2: 943\                                                                                                                                                               
                                                                                                                                                                                                                                   Group 3: Control: 52.2 ± 3.5\                                                                                                                                                                                    Group 3: 506                                                                                                                                                                
                                                                                                                                                                                                                                   LS: 54.5 ± 4.2                                                                                                                                                                                                                                                                                                                                                                               

  Group 2 aortic arm leg                                     −21.8 \*\*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                             −10.7 \*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                             −13.3 \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Group 3 aortic leg                                         −22.7 \*\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                             −22.3 \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  **hfPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Rhee MY. (2016) \[[@B45-nutrients-12-00005]\]              Korea                           RCT                          NT and HT adults                                                            M/F       N/AV       101     46.0 ± 16.6                         2                                       LS DASH diet: 2320 mg Na/d\                                                           N/AV                                           LS diet: 2320\                                                              US                                           HS vs. LS                                          
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 vs.\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                               HS DASH diet: 7000 mg Na/d                                                                                                           HS diet: 7000                                                                                                                                                               

  SS                                                         +4% \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  SR                                                         ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  HT                                                         ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  NT                                                         ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **baPWV**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Wang Y. (2015) \[[@B46-nutrients-12-00005]\]               China                           dietary intervention study   mild HT adults                                                              M/F       N/AV       49      49.0 ± 7.9                          3 (1 week × three diets)                LS diet: 1179.9 mg/d &\                                                               24hU                                           3999.7 ± 1543.3                                                             plethysmography                              LS vs. HS                     ≠                    
                                                                                                                                                                                                                                                                                                               HS diet: 7079.4 mg/d                                                                                                                                                                                                                                                                                             

  SS vs. SR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Baseline                                                   +2.3 \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  After LS                                                   +1.5 \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  After HS                                                   +2.0 \*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  **Arterial Elasticity (Arterial Compliance)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  **Author**                                                 **Country**                     **Study Design**             **Population Description**                                                  **Sex**   **Race**   **N**   **Age (Years, Mean ± SD)**          **Intervention Duration**               **Type of Diet**                                                                      **Na Estimation Method**                       **Na Intake/Excretion (mg/d)**                                              **Vascular Assessment**                      **Results**                                        

  **Intervention Groups**                                    **Vascular Change (mm/mmHg)**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Creager MA. (1991) \[[@B47-nutrients-12-00005]\]           USA                             cross-over RCT               NT men                                                                      M         N/AV       17      30 ± 2 years                        10 days                                 LS diet: 230 mg Na/d\                                                                 24hU                                           LS: 253 ± 46\                                                               diastolic blood pressure time decay method   LS vs. HS                     ≠                    
                                                                                                                                                                                                                                                                                                               vs.\                                                                                                                                 vs.\                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                               HS diet: 4600 mg Na/d                                                                                                                HS: 4117 ± 207                                                                                                                                                              

  Gates PE. (2004) \[[@B48-nutrients-12-00005]\]             USA                             cross-over dbRCT             stage 1 HT adults, older than 50                                            M/F       White      12      men: 63 ± 1\                        8 weeks                                 LS diet: 1196 ± 92\                                                                   3 day dietary records & 24hU                   Na excretion\                                                               B-mode US                                    LS                            +0.04 \*             
                                                                                                                                                                                                                                   women: 64 ± 4                                                               &\                                                                                                                                   Baseline: 3105\                                                                                                                                                             
                                                                                                                                                                                                                                                                                                               Normal Na diet: 1311 ± 23                                                                                                            LS: 1380\                                                                                                                                                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                    Normal Na: 3450                                                                                                                                                             

  Normal                                                     ≠                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The mmol of Na intake/excretion values were converted to mg. If available, results presented come from adjusted models. Abbreviations: Na: sodium; 24hU: 24h urine collection; cfPWV: carotid--femoral pulse wave velocity; baPWV: brachial--ankle pulse wave velocity; hfPWV: heart-femoral pulse wave velocity; HT: hypertensives; NT: normotensives; PHT: pre-hypertensives; HTN: hypertension; SBP: systolic blood pressure; anti-HT: antihypertensive; OW: overweight; OB: obese; NOB: non-obese; suppl: supplementation; HS: high sodium; LS: low sodium; SS: salt sensitive; SR: salt resistant; RCT: randomized controlled trial; sbRCT: single-blind RCT; dbRCT: double-blind RCT; M/F: males & females; F: females; M: males; N/AV: not available; CKD: chronic kidney disease; US: ultrasonography; ≠: no statistically significant association; \*: *p* \< 0.05; \*\*: *p* \< 0.01.

nutrients-12-00005-t003_Table 3

###### 

Descriptive characteristics of observational studies regarding arterial remodeling.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Arterial Remodeling                                                                                                                                                                                                                                                                                                                                                                              
  --------------------------------------------------------------- ------------- ------------------ ---------------------------------------------------------------- ---------------- --------- ---------- ------- ------------------------------------------ ----------------------------------------- --------------------------------------------------- ------------------------- ------------- ---
  **1. Observational Cross-Sectional Studies**                                                                                                                                                                                                                                                                                                                                                     

  **Author (Year)**                                               **Country**   **Study Design**   **Population Description**                                       **FU (Years)**   **Sex**   **Race**   **N**   **Age (Years, Mean ± SD)**                 **Na Estimation Method**                  **Na Intake/Excretion (mg/d)**                      **Vascular Assessment**   **Results**   

  Ferreira-Sae, M.C. (2011) \[[@B33-nutrients-12-00005]\]         Brazil        c-sect             HT adults                                                        \-               M/F       N/AV       134     58 ± 1                                     1\. FFQ\                                  Na intake/d: 5520 ± 290\                            B-mode US                 \+ \*         
                                                                                                                                                                                                                                                             2. 24h recall\                             FFQ: 1450 ± 180\                                                                           
                                                                                                                                                                                                                                                             3. discretionary Na intake ^1^             24h recall: 940 ± 70\                                                                      
                                                                                                                                                                                                                                                                                                        Discretionary Na: 3130 ± 190                                                               

  Njoroge, J.N. (2011) \[[@B49-nutrients-12-00005]\]              USA           c-sect             OW or OB, physically inactive adults                             \-               M/F       Mixed      258     Total: 38.5 ± 5.8\                         24hU                                      Total:1104--9545\                                   B-mode US                 \+ \*         
                                                                                                                                                                                                                  Q1: 39.3 ± 5.6\                                                                      Q1: 1104--3289\                                                                             
                                                                                                                                                                                                                  Q2: 38.7 ± 5.2\                                                                      Q2: 3312--4117\                                                                             
                                                                                                                                                                                                                  Q3: 37.6 ± 6.2\                                                                      Q3: 4140--5152\                                                                             
                                                                                                                                                                                                                  Q4: 38.2 ± 6                                                                         Q4: 5175--9545                                                                              

  García-Ortiz, L. (2012) \[[@B23-nutrients-12-00005]\]           Spain         c-sect             primary care patients aged 30--80                                \-               M/F       N/AV       351     Total: 54.8 ± 11.7\                        FFQ                                       Total: 3180 ± 1250\                                 B-mode US                 J-shaped      
                                                                                                                                                                                                                  Q1: 57.6 ± 12.1\                                                                     Q1:1800 ± 390\                                                                              
                                                                                                                                                                                                                  Q2: 55.9 ± 11.3\                                                                     Q2: 2650 ± 200\                                                                             
                                                                                                                                                                                                                  Q3: 54.7 ± 10.5                                                                      Q3: 3440 ± 270                                                                              

  Lee SK. (2015) \[[@B16-nutrients-12-00005]\]                    Korea         c-sect             non-HT subjects, with no use of anti-HT drugs                    \-               M/F       Asian      1586    tertile 1: 52.1 ± 5.5\                     second morning void & Tanaka's equation   3588 ± 782                                          B-mode US                 − \*\*        
                                                                                                                                                                                                                  tertile 2: 53.0 ± 6.0\                                                                                                                                                           
                                                                                                                                                                                                                  tertile 3: 52.6 ± 5.5                                                                                                                                                            

  Ustundag, S. (2015) \[[@B50-nutrients-12-00005]\]               Turkey        c-sect             ambulatory adult patients, in stage 2--4 CKD                     \-               M/F       N/AV       193     Na excretion \<1955 mg/day: 47.7 ± 10.6\   24hU                                      \<1955 mg/day: 3220 ± 69 ≥1955 mg/day: 3220 ± 69\   B-mode US                 \+ \*\*       
                                                                                                                                                                                                                  ≥1955 mg/day: 49.7 ± 11.0\                                                           Mean IMT \< 0.750 mm: 3220 ± 46\                                                            
                                                                                                                                                                                                                  Mean IMT\                                                                            Mean IMT ≥ 0.750 mm: 3220 ± 69                                                              
                                                                                                                                                                                                                  \<0.750 mm: 45.1 ± 12.2\                                                                                                                                                         
                                                                                                                                                                                                                  ≥0.750 mm: 52.3 ± 8.3                                                                                                                                                            

  Dai, X.W. (2016) \[[@B19-nutrients-12-00005]\]                  China         c-sect             Asian adults, via subject referral and community advertisement   \-               M/F       Asian      3290    M: 62.1 ± 6.7\                             FFQ                                       Dietary Na intake:\                                 B-mode US                 common cIMT   ≠
                                                                                                                                                                                                                  F: 59.4 ± 5.5                                                                        Q1: 833 ± 394\                                                                              
                                                                                                                                                                                                                                                                                                       Q2: 864 ± 507\                                                                              
                                                                                                                                                                                                                                                                                                       Q3: 825 ± 41\                                                                               
                                                                                                                                                                                                                                                                                                       Q4: 828 ± 395                                                                               

  carotid bifurcation IMT                                         \+ \*                                                                                                                                                                                                                                                                                                                            

  Mazza, E. (2018) \[[@B20-nutrients-12-00005]\]                  Italy         c-sect             adults aged ≥65, not suffering from any debilitating diseases    \-               F         White      108     70 ± 4                                     24h dietary recall + 7 day food record    1476 ± 618                                          B-mode US                 \+ \*         

  **2. Observational Studies with Follow up (\>1 Time Points)**                                                                                                                                                                                                                                                                                                                                    

  Jung, S. (2019) \[[@B15-nutrients-12-00005]\]                   South Korea   prosp              adults aged \>40                                                 5.4 ± 1.0        M/F       Mixed      2494    60.2 ± 9.0                                 FFQ + 3 day diet record                   2644 ± 1573                                         B-mode US                 **cIMT**      

  Na baseline                                                     ≠                                                                                                                                                                                                                                                                                                                                

  Na average of three visits                                      \+ \*\*                                                                                                                                                                                                                                                                                                                          

  **ΔcIMT**                                                                                                                                                                                                                                                                                                                                                                                        

  Na baseline                                                     ≠                                                                                                                                                                                                                                                                                                                                

  Na average of three visits                                      − \*                                                                                                                                                                                                                                                                                                                             
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The mmol of Na intake/excretion values were converted to mg. If available, results presented come from adjusted models. Abbreviations: Na: sodium; 24hU: 24h urine collection; cIMT: carotid Intima Media Thickness; HT: hypertensives; anti-HT: antihypertensive; OW: overweight; OB: obese; c-sect: cross-sectional; prosp: prospective; FFQ: food frequency questionnaire; FU: follow up; M/F: males & females; F: females; N/AV: not available; CKD: chronic kidney disease; US: ultrasonography; +: positive association; -: negative association; ≠: no statistically significant association; \*: *p* \< 0.05; \*\*: *p* \< 0.01. ^1^ number of 1 kg packages of salt consumed/month/person.

nutrients-12-00005-t004_Table 4

###### 

Descriptive characteristics of interventional studies regarding arterial remodeling.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Arterial Remodeling                                                                                                                                                                                                                                                                                                                 
  -------------------------------------------------- ------------- ------------------ ---------------------------------------------- ----- ------ ---- ------------ --- ----------------------------------------------------------------------------------------------------------------- ------ ------------------------ ----------- ---------------------
  Benetos, A. (1992) \[[@B51-nutrients-12-00005]\]   France        cross-over dbRCT   actively working, mild to moderate HT adults   M/F   N/AV   20   41.5 ± 2.4   8   Group 1 and Group 2: Normal Na diet (NS diet, Na capsules): 1400 mg and low-Na diet (LS diet), lactose capsules   24hU   Baseline: 3979 ± 299\    B-mode US   LS diet vs. NS diet
                                                                                                                                                                                                                                                                                                 LS diet: 1955 ± 220.8\               
                                                                                                                                                                                                                                                                                                 NS diet: 3749 ± 305.9                

  Brachial artery diameter                           +0.67m \*\*                                                                                                                                                                                                                                                                      

  common carotid diameter                            ≠                                                                                                                                                                                                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The mmol of Na intake/excretion values were converted to mg. If available, results presented come from adjusted models. Abbreviations: sodium; 24hU: 24h urine collection; HT: hypertensives; LS: low sodium; dbRCT: double-blind RCT; M/F: males & females; N/AV: not available; US: ultrasonography; ≠: no statistically significant association; \*\*: *p* \< 0.01.

nutrients-12-00005-t005_Table 5

###### 

Descriptive characteristics of observational studies regarding atheromatosis.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Atheromatosis                                                                                                                                                                                                                                                
  ------------------------------------------------ ------- -------- ---------------------------------------------------------------- ---- ----- ------- ------ ---------------- ---------------------------------------- ------------------------- ----------- --------------------------------
  Dai, X.W. (2016) \[[@B19-nutrients-12-00005]\]   China   c-sect   Asian adults, via subject referral and community advertisement   \-   M/F   Asian   3290   M: 62.1 ± 6.7\   FFQ                                      Dietary Na intake:\       B-mode US   ≠
                                                                                                                                                               F: 59.4 ± 5.5                                             Q1: 833 ± 394\                        
                                                                                                                                                                                                                         Q2: 864 ± 507\                        
                                                                                                                                                                                                                         Q3: 825 ± 41\                         
                                                                                                                                                                                                                         Q4: 828 ± 395                         

  Mazza, E. (2018) \[[@B20-nutrients-12-00005]\]   Italy   c-sect   Adults aged ≥65, not suffering from any debilitating diseases    \-   F     White   108    70 ± 4           24h dietary recall + 7 day food record   1476 ± 618\               B-mode US   Tertile III vs. Tertile I + \*
                                                                                                                                                                                                                         Tertile I: 780--900\                  
                                                                                                                                                                                                                         Tertile II: 1330--1430\               
                                                                                                                                                                                                                         Tertile III: 2050--2330               
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The mmol of Na intake/excretion values were converted to mg. If available, results presented come from adjusted models. Abbreviations: Na: sodium; c-sect: cross-sectional; FFQ: food frequency questionnaire; FU: follow up; M/F: males & females; F: females; US: ultrasonography; +: positive association; ≠: no statistically significant association; \*: *p* \< 0.05.
